Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Increase the proportion of people with sickle cell disease on Medicare who received disease-modifying therapies — BDBS‑02 Data

Status: Baseline only

  Baseline only

Most Recent Data:
12.4 percent (2016)

Target:
15.9 percent

Desired Direction:
Increase desired

Baseline:
12.4 percent of Medicare beneficiaries aged 18 to 75 years with sickle cell anemia received disease modifying therapies in accordance with the National Heart, Lung, and Blood Institute (NHLBI)'s guidelines in 2016

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Medicare beneficiaries with sickle cell anemia receiving disease modifying therapies, 2016 
(percent)
Increase desired

Population 2016
Total
12.4